Study Details
Full Title
DCA12: A Multicenter, Open-label, Long-term Extension Study for Oral Levosimendan (TNX-103-08)
Principal Investigator
Marat
Fudim
Protocol Number
PRO00120435
NCT ID
NCT07436689
Phase
III
Enrollment Status
Open to Enrollment